Lipoprotein(a) Reduction in Persons with Cardiovascular Disease - Tsimikas, Sotirios; Karwatowska-Prokopczuk, Ewa; Gouni-Berthold, Ioanna; Tardif, Jean-Claude; Baum, Seth J; Steinhagen-Thiessen, Elizabeth; Shapiro, Michael D; Stroes, Erik S; Moriarty, Patrick M; Nordestgaard, Børge G; Xia, Shuting; Guerriero, Jonathan; et al. (The New England journal of medicine, 2020)
Keywords: Adult; Aged; Antisense oligonucleotides; Aortic stenosis; Apolipoproteins; Blood platelets; Blood pressure; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - blood; Cardiovascular Diseases - drug therapy; Cholesterol - blood; Dose-Response Relationship, Drug; Double-Blind Method; Drug dosages; Female; Health risk assessment; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Hypolipidemic Agents - administration & dosage; Hypolipidemic Agents - adverse effects; Hypolipidemic Agents - therapeutic use; Influenza; Laboratories; Least-Squares Analysis; Lipoprotein(a) - blood; Low density lipoprotein; Male; Middle Aged; Oligonucleotides - administration & dosage; Oligonucleotides - adverse effects; Patients; Risk Factors; Stenosis; Urine